Sorted By:

Relevance


ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Create a new safe harbor to the AKS to protect value-based arrangements and provide clarity for companies.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Create a new safe harbor to the AKS to protect value-based arrangements and provide clarity for companies.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

A Day In The Life

PhRMA  |  From PhRMA

                     
https://www.phrma.org/media/a-day-in-the-life

Because One Day Isn't Enough

PhRMA  |  Blog Post

So, I imagine my $400 or so (I no longer remember the exact amount) probably didn't get too far.
http://catalyst.phrma.org/because-one-day-isnt-enough

Research in New Jersey

PhRMA  |  Research In Your Backyard

These clinical trials have investigated or are investigating some of New Jersey’s biggest healthcare challenges, including asthma, arthritis, cancer, diabetes, cardiovascular disease and Alzheimer’s disease.
https://www.phrma.org/research-in-your-backyard/research-in-new-jersey

National Drug Take Back Day

PhRMA  |  Blog Post

In addition to DEA’s National Take Back Day, local communities will often organize a local medication take back event during various times of the year.
http://catalyst.phrma.org/national-drug-take-back-day

Draft Policy Portal

PhRMA  |  From PhRMA

...
https://www.phrma.org/utility

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

PhRMA  |  Blog Post

For more information on Part D, visit: PhRMA.org/PartD.
http://catalyst.phrma.org/medicare-monday-why-imposing-medicaid-style-rebates-in-part-d-is-a-bad-idea

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/catalyst-dev/new-report-highlights-more-than-250-vaccines-in-development-0

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

Check out the previous chapters of .com/together?
http://catalyst.phrma.org/new-video-patient-and-researcher-fight-jra-together

Mental health in the New Era of Medicine

PhRMA  |  Blog Post

To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit www.innovation.org.  
http://catalyst.phrma.org/mental-health-in-the-new-era-of-medicine

VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY

PhRMA  |  Blog Post

    Visit GoBoldly.com and Innovation.org to learn more about #GOBOLDLY.
http://catalyst.phrma.org/video-phrma-ceo-joins-cnbcs-squawk-on-the-street-to-discuss-new-industry-campaign-go-boldly

Where'd My Discount Go?

PhRMA  |  Graphic

Learn more at PhRMA.org/discounts.
https://www.phrma.org/where-did-my-discount-go

Alzheimer's Webinar - July 15, 2015 at 1:30 pm EDT

PhRMA  |  Video

  New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of TomorrowRead PhRMA's Press Release on the Summer 2015 report
https://www.phrma.org/video/alzheimer-s-webinar-july-15-2015-at-1-30-pm-edt

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

PhRMA  |  Blog Post

Listen to the full interview here, and visit .com/?
http://catalyst.phrma.org/phrma-ceo-talks-white-house-meeting-innovation-jobs-with-politicos-pulse-check

PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post


http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist

PhRMA  |  Blog Post

Despite the day-to-day uncertainty of the disease, Amber is hopeful for her own course of treatment and the many new options being developed.
http://catalyst.phrma.org/fighting-multiple-sclerosis-new-together-ad-illuminates-the-journey-of-patient-scientist

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

PhRMA  |  Blog Post

To learn more about the 340B program, visit PhRMA.org/340B.
http://catalyst.phrma.org/340b-spotlight-icymi-340b-hearing-new-reports-highlight-growing-need-for-program-reform

Medicare Monday: PhRMA's comments on new direction for CMMI

PhRMA  |  Blog Post

Read our full comments here, and learn more at PhRMA.org/CMMI.
http://catalyst.phrma.org/medicare-monday-phrmas-comments-on-new-direction-for-cmmi

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

PhRMA  |  Blog Post

Visit PhRMA.org/LetsTalkCost to learn more.
http://catalyst.phrma.org/video-phrma-ceo-discusses-medicine-costs-with-cnbcs-squawk-box

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/press-release/phrma-announces-support-for-seven-day-script-limit-on-opioid-medicines-for-acute-pain

340B Spotlight: ICYMI – AJC looks at how some Georgia hospitals are profiting off 340B

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
http://catalyst.phrma.org/340b-spotlight-icymi-ajc-looks-at-how-some-georgia-hospitals-are-profiting-off-340b

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

The answer is yes.
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

New report provides recommendations for securing and protecting IP

PhRMA  |  Blog Post

Without the security of a strong IP system, biopharmaceutical researchers may not have the ability to explore new areas of medical innovation and unearth the findings that will lead to the treatments of tomorrow.
http://catalyst.phrma.org/new-report-provides-recommendations-for-securing-and-protecting-ip

Medicare Monday: What does Medicare Part B Cover?

PhRMA  |  Blog Post

Check back with Medicare Monday for more on Part B and other aspects of Medicare next week.
http://catalyst.phrma.org/medicare-monday-what-does-medicare-part-b-cover

You have reviewed the first 50 results out of 2100. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next